Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
about
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy and safety of saxagli ...... 36-week open-label extension.
@en
Efficacy and safety of saxagli ...... 36-week open-label extension.
@nl
type
label
Efficacy and safety of saxagli ...... 36-week open-label extension.
@en
Efficacy and safety of saxagli ...... 36-week open-label extension.
@nl
prefLabel
Efficacy and safety of saxagli ...... 36-week open-label extension.
@en
Efficacy and safety of saxagli ...... 36-week open-label extension.
@nl
P2093
P2860
P1476
Efficacy and safety of saxagli ...... 36-week open-label extension.
@en
P2093
Ryutaro Shimazaki
Satsuki Muto
Takashi Kadowaki
Yoshiumi Ouchi
Yutaka Seino
P2860
P304
P356
10.1080/14656566.2017.1379990
P407
P577
2017-09-13T00:00:00Z